title: Dissociation of KATP channel and sulphonylurea receptor in the rat clonal insulin-secreting cell line, CRI-D11.
abstract: It is generally considered that the sulphonylurea receptor is an integral part of the ATP-sensitive K+ channel. We have investigated this proposal by comparing the binding and functional characteristics of the sulphonylurea receptor and KATP channel by using two rat insulinoma cell lines (CRI-G1 and CRI-D11) of common origin. Insulin release was increased in both cell lines by a variety of metabolizable and non-metabolizable secretagogues but glibenclamide induced an increase in insulin release in G1 cells only. [3H]glibenclamide binding studies showed a substantial reduction in the number of glibenclamide binding sites (Bmax) in the D11 cells compared with G1 cells. Single-channel studies of these cell lines show that the KATP channel is generally unchanged in its biophysical properties and in the number of channels observed. Slight differences were apparent: the KATP channels in D11 cells were much less susceptible to rundown and were slightly less sensitive to block by ATP. However, one major distinction was the lack or much reduced sensitivity of the KATP channel in D11 cells to tolbutamide and glibenclamide. We conclude that the KATP channel can exist and function independently of the sulphonylurea receptor, and therefore it is unlikely that they exist as a single protein assembly.
authors.affiliation: Department of Pharmacology, University of Cambridge, U.K.
authors.forename: R N
authors.initials: RN
authors.lastname: Khan
authors.forename: C N
authors.initials: CN
authors.lastname: Hales
authors.forename: S E
authors.initials: SE
authors.lastname: Ozanne
authors.forename: A A
authors.initials: AA
authors.lastname: Adogu
authors.forename: M L
authors.initials: ML
authors.lastname: Ashford
mesh_terms: D015056:1-Methyl-3-isobutylxanthine / Q000494:pharmacology; D018528:ATP-Binding Cassette Transporters; D000255:Adenosine Triphosphate / Q000494:pharmacology*; D000818:Animals; D002462:Cell Membrane / Q000378:metabolism; D002999:Clone Cells; D005905:Glyburide / Q000378:metabolism / Q000494:pharmacology; D007328:Insulin / Q000378:metabolism*; D000078790:Insulin Secretion; D007340:Insulinoma; D008564:Membrane Potentials / Q000187:drug effects; D010190:Pancreatic Neoplasms; D011188:Potassium / Q000494:pharmacology; D015221:Potassium Channels / Q000187:drug effects / Q000378:metabolism* / Q000502:physiology*; D024661:Potassium Channels, Inwardly Rectifying; D051381:Rats; D011955:Receptors, Drug / Q000187:drug effects / Q000378:metabolism*; D064233:Sulfonylurea Receptors; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology; D014044:Tolbutamide / Q000494:pharmacology; D014407:Tumor Cells, Cultured
chemical_list: D018528:ATP-Binding Cassette Transporters; D007328:Insulin; D015221:Potassium Channels; D024661:Potassium Channels, Inwardly Rectifying; D011955:Receptors, Drug; D064233:Sulfonylurea Receptors; D000255:Adenosine Triphosphate; D014044:Tolbutamide; D013755:Tetradecanoylphorbol Acetate; D011188:Potassium; D005905:Glyburide; D015056:1-Methyl-3-isobutylxanthine